Insights

Growing Market Demand With over 500 million people globally living with respiratory allergies and increasing prevalence of food allergies, there is a significant and expanding demand for allergy diagnostic and treatment solutions, presenting a substantial sales opportunity for healthcare providers and pharmaceutical distributors.

Innovation and Heritage ALK has a long-standing history of leadership in allergy treatments and is now evolving with its Allergy+ initiative, highlighting opportunities to promote advanced, long-term allergy management products to healthcare systems seeking innovative solutions.

Global Expansion Recent developments such as Alaska Airlines launching new international routes to Europe demonstrate the company's ongoing global expansion, which may necessitate enhanced medical and wellness services for international travelers, opening avenues for specialized health product sales.

Digital Engagement ALK employs a variety of digital tools including LinkedIn Ads and Pardot, indicating a sophisticated approach to digital marketing—creating pathways to promote allergy management solutions directly to healthcare professionals and consumers via targeted online campaigns.

Financial Growth Potential With a revenue range between 1 billion and 10 billion dollars and a global workforce of nearly 3,000 employees, ALK represents a financially robust company with ongoing investment potential, ideal for strategic partnerships in drug supply, medical technology, and healthcare services.

ALK Tech Stack

ALK uses 8 technology products and services including LinkedIn Ads, Veeam, SCADA, and more. Explore ALK's tech stack below.

  • LinkedIn Ads
    Advertising
  • Veeam
    Backup And Recovery
  • SCADA
    Control Systems
  • Apple iCloud Mail
    Email
  • Microsoft Active Directory
    Identity And Access Management
  • Underscore.js
    Javascript Libraries
  • Pardot
    Marketing
  • X-XSS-Protection
    Security

Media & News

ALK's Email Address Formats

ALK uses at least 1 format(s):
ALK Email FormatsExamplePercentage
First.Last@alk.netJohn.Doe@alk.net
84%
FLast@alk.netJDoe@alk.net
8%
FirstLas@alk.netJohnDoe@alk.net
5%
First.Middle.Last@alk.netJohn.Michael.Doe@alk.net
3%

Frequently Asked Questions

Where is ALK's headquarters located?

Minus sign iconPlus sign icon
ALK's main headquarters is located at ALK Corporate Headquarters Boege Alle 1 Hoersholm, DK-2970 DK. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is ALK's stock symbol?

Minus sign iconPlus sign icon
ALK is a publicly traded company; the company's stock symbol is ALK.

What is ALK's official website and social media links?

Minus sign iconPlus sign icon
ALK's official website is alk.net and has social profiles on LinkedIn.

How much revenue does ALK generate?

Minus sign iconPlus sign icon
As of October 2025, ALK's annual revenue is estimated to be $703M.

What is ALK's SIC code NAICS code?

Minus sign iconPlus sign icon
ALK's SIC code is 2830 - Drugs NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ALK have currently?

Minus sign iconPlus sign icon
As of October 2025, ALK has approximately 2.9K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: C. S.Chief Qa Professional: K. A.Vice President Partner Markets: M. E.. Explore ALK's employee directory with LeadIQ.

What industry does ALK belong to?

Minus sign iconPlus sign icon
ALK operates in the Pharmaceutical Manufacturing industry.

What technology does ALK use?

Minus sign iconPlus sign icon
ALK's tech stack includes LinkedIn AdsVeeamSCADAApple iCloud MailMicrosoft Active DirectoryUnderscore.jsPardotX-XSS-Protection.

What is ALK's email format?

Minus sign iconPlus sign icon
ALK's email format typically follows the pattern of First.Last@alk.net. Find more ALK email formats with LeadIQ.

When was ALK founded?

Minus sign iconPlus sign icon
ALK was founded in 1923.
ALK

ALK

Pharmaceutical ManufacturingDK-2970, Denmark1001-5000 Employees

We are the pioneers of allergy solutions. Allergy is the most common chronic disease globally and it has profound impact on people’s lives. More than 500 million people worldwide live with respiratory allergies, more than 200 million people have some sort of food allergy, and more than 100 million children are living with allergic rhinitis. These numbers are only expected to increase, and as a result, the need for allergy solutions is ever-growing.

For more than a 100 years, ALK has been at the forefront of long-term allergy treatment. Building on our strong heritage, we are now stepping into the next 100 years with a mission to help even more people, with more solutions, more efficiently. We call it Allergy+.

ALK is a global company with production sites in Denmark, France, Spain and the United States. ALK was founded in Copenhagen in 1923 and today we employ around 2,900 people around the world. Our global headquarters is located in beautiful surroundings in Hørsholm, north of Copenhagen.

Read more about ALK at www.alk.net

Section iconCompany Overview

Headquarters
ALK Corporate Headquarters Boege Alle 1 Hoersholm, DK-2970 DK
Website
alk.net
SIC Code
2830 - Drugs
Stock Symbol
ALK
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1923
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    ALK's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    ALK's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.